Characterization of 24-hour Lung Function Profiles of Inhaled Tiotropium + Olodaterol Fixed Dose Combination in Patients Suffering From Chronic Obstructive Pulmonary Disease

NCT01559116 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

219

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: tiotropium + olodaterol
DRUG: tiotropium
DRUG: olodaterol
DRUG: tiotropium
DRUG: tiotropium + olodaterol
DRUG: Placebo
DEVICE: Respimat

Sponsor

Boehringer Ingelheim